|1.||Seibold, Frank: 6 articles (11/2010 - 03/2004)|
|2.||Poulain, Daniel: 6 articles (01/2010 - 02/2003)|
|3.||Apostolopoulos, Vasso: 4 articles (05/2015 - 03/2007)|
|4.||Ohno, Naohito: 4 articles (01/2014 - 05/2008)|
|5.||Flogerzi, Beatrice: 4 articles (11/2010 - 03/2004)|
|6.||Poulain, D: 4 articles (12/2008 - 08/2001)|
|7.||Sendid, Boualem: 4 articles (04/2008 - 02/2003)|
|8.||Wu, Yang: 3 articles (01/2015 - 06/2011)|
|9.||Tada, Rui: 3 articles (01/2014 - 05/2008)|
|10.||Adachi, Yoshiyuki: 3 articles (01/2014 - 05/2008)|
01/01/1991 - "It is possible that understanding the immunosuppressive effects of mannan will provide clues to novel therapies for candidiasis that will enhance the efficacy of both available and future anti-Candida agents."
11/01/2011 - "Logistic regression analysis showed that this was probably due to the fact that circulating mannan was also being detected by the Ag Plus assay in patients with superficial candidiasis. "
11/02/2009 - "albicans significantly changes the mannan structures under various stress conditions and that sufficient attention to the cultural conditions is needed to perform an accurate diagnosis of candidiasis."
06/01/1999 - "Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis."
05/01/1999 - "These observations, which clearly demonstrate a disparity between circulation of a given mannan catabolite and antimannan antibody response, suggest that use of both enzyme immunoassays may be useful for the routine diagnosis of candidiasis."
03/01/1990 - "The neutral mannan (WNM) and the acidic mannan (WAM025) fractions from baker's yeast (Saccharomyces cerevisiae) were found to manifest significant protective effects against intraperitoneal and intravenous infections of Listeria monocytogenes and Pseudomonas aeruginosa in mice. "
09/01/2004 - "The overall results demonstrate that mannan can be used to enhance certain non-lethal influenza virus infections sufficiently to allow antiviral studies."
07/01/2014 - "This retrospective study was based on follow-up from the investigation of 162 patients of whom 91 had proven ICI; 13 had Candida colonization index (CCI) scores ≥0.42, positive mannan tests, with nonconcomitant infections; and 58 had no evidence of Candida infection. "
07/01/2013 - "Candida mannan (Mn) detection in bronchoalveolar lavage fluid (BALF) was shown to be useful for earlier identification and preemptive therapy targeting in preterm infants at high risk of invasive Candida infection. "
06/01/2013 - "We evaluated the effect of dietary supplementation with mannan oligosaccharide (MOS) on the resistance to Aeromonas hydrophi1a infection in Allogynogenetic crucian carp. "
01/01/2014 - "Serological tests, especially mannan and anti-mannan ones, are very useful for confirmation or exclusion of invasive candidiasis in high-risk patients. "
07/01/2014 - "Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis."
01/01/1996 - "The mean anti-mannan antibody titers determined in a group of 36 immunocompromised patients with invasive candidiasis increased within two weeks after the probable onset of invasive candidiasis. "
06/01/1992 - "Mannan antigenemia during invasive candidiasis caused by Candida tropicalis."
11/01/1991 - "However, the mannan level was low (less than 2.0 ng/ml) in the serum of 63.2% of the patients with invasive candidiasis. "
06/06/2011 - "In this study a recombinant adenovirus vector modified with mannan was used to deliver VE-cad (AdVEC-m) and we tried to explore its feasibility as an antitumour agent in mouse cancer models. "
05/01/2006 - "[Experimental study of anti-cancer effect of Mannan-modified targeted nanoliposome on mice]."
05/01/2014 - "Our data suggest that the combination of cancer immunity and anti-angiogenesis via modified mannan is a promising strategy in tumor prophylaxis and therapy."
05/01/2006 - "The mannan-modified targeted nanoliposome has anti-cancer effect on mice."
05/01/2006 - "The growth of tumor has been inhibited by mannan-modified targeted nanoliposome. "
|5.||Atherosclerotic Plaque (Atheroma)
01/01/2012 - "Positing that improved USPIO with a higher affinity for atherosclerotic plaques would yield better plaque images, we performed MRI and histologic studies to compare the uptake of dextran- and mannan-dextran-coated USPIO (D-USPIO and DM-USPIO, respectively) by the atherosclerotic walls of rabbits. "
|6.||ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)
|7.||Complement System Proteins (Complement)
|10.||Heat-Shock Proteins (Heat-Shock Protein)
|1.||Drug Therapy (Chemotherapy)
|3.||Stem Cell Transplantation
|4.||Transplantation (Transplant Recipients)
|5.||Hematopoietic Stem Cell Transplantation